Webster Bank N. A. Has $1.91 Million Stake in Cerner Co. (CERN)
Webster Bank N. A. cut its holdings in shares of Cerner Co. (NASDAQ:CERN) by 11.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 28,256 shares of the company’s stock after selling 3,519 shares during the period. Webster Bank N. A.’s holdings in Cerner were worth $1,905,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of CERN. Thrivent Financial For Lutherans grew its position in shares of Cerner by 3.1% during the 2nd quarter. Thrivent Financial For Lutherans now owns 11,110 shares of the company’s stock valued at $738,000 after acquiring an additional 330 shares during the period. Mutual of America Capital Management LLC grew its position in shares of Cerner by 2.8% during the 2nd quarter. Mutual of America Capital Management LLC now owns 35,814 shares of the company’s stock valued at $2,381,000 after acquiring an additional 985 shares during the period. Lazard Asset Management LLC acquired a new stake in shares of Cerner during the 2nd quarter valued at about $5,922,000. UBS Asset Management Americas Inc. lifted its stake in Cerner by 6.0% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 840,607 shares of the company’s stock valued at $55,875,000 after buying an additional 47,461 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new position in Cerner in the 2nd quarter valued at about $293,000. Hedge funds and other institutional investors own 81.85% of the company’s stock.
CERN has been the topic of a number of research reports. Zacks Investment Research raised shares of Cerner from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. Stifel Nicolaus reaffirmed a “hold” rating on shares of Cerner in a research note on Wednesday, November 22nd. JPMorgan Chase & Co. lowered shares of Cerner from an “overweight” rating to a “neutral” rating in a research note on Friday, October 27th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $77.00 price target on shares of Cerner in a research note on Thursday, October 12th. Finally, Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a research note on Wednesday, October 25th. Seventeen equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $70.21.
Cerner (NASDAQ:CERN) last released its earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.62 by ($0.01). Cerner had a return on equity of 18.03% and a net margin of 13.37%. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same period last year, the business earned $0.59 earnings per share. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. sell-side analysts forecast that Cerner Co. will post 2.24 EPS for the current year.
In other Cerner news, VP Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total value of $279,560.00. Following the transaction, the vice president now directly owns 4,000 shares of the company’s stock, valued at approximately $279,560. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Marc G. Naughton sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $70.64, for a total transaction of $4,238,400.00. The disclosure for this sale can be found here. Insiders sold a total of 788,000 shares of company stock worth $52,190,800 over the last three months. Corporate insiders own 13.11% of the company’s stock.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.